Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Oragenics Inc
OGENCurrent price
0.48 USD
-0.024 USD (-4.73%)
Last closed
0.5 USD
Company
www.oragenics.com
ISIN
US6840233026
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Capitalization
4 582 380 USD
Yield for 12 month
-83.90 %
1Y
3Y
5Y
10Y
15Y
OGEN
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida. Address: 4902 Eisenhower Boulevard, Tampa, FL, United States, 33634
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
90 USDP/E ratio
–Dividend Yield
–Current Year
+37 653 USD
Last Year
+131 521 USD
Current Quarter
–
Last Quarter
–
Current Year
+10 262 USD
Last Year
+86 854 USD
Current Quarter
–
Last Quarter
-663 414 USD
Key Figures OGEN
1 year
3 years
5 years
10 years
EBITDA
-19 638 392 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-219.89 %
PEG Ratio
–
Return On Equity TTM
-454.72 %
Wall Street Target Price
90 USD
Revenue TTM
7 466 USD
Book Value
-0.048 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-91.3 %
Dividend Yield
–
Gross Profit TTM
-9 941 163 USD
Earnings per share
-7.33 USD
Diluted Eps TTM
-7.33 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics OGEN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OGEN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:60
Payout Ratio
–
Last Split Date
23.01.2023
Dividend Date
22.01.2018
Stock Valuation OGEN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
105.8267
Price Sales TTM
613.7664
Enterprise Value EBITDA
0.2113
Price Book MRQ
7.5667
Financials OGEN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OGEN
For 52 weeks
0.47 USD
7.74 USD
50 Day MA
1.04 USD
Shares Short Prior Month
42 738
200 Day MA
2.3 USD
Short Ratio
0.95
Shares Short
1 320 570
Short Percent
26.14 %
BeatStart